Technical Advisory Board

Technical Advisory Board  


Ali Afnan, Ph.D.
StepChange Pharma, Inc.

Ali Afnan is President of StepChange Pharma, Inc. a pharmaceutical industry technical consultancy focused on process design and development, process analytical technology (PAT), Quality by Design (QbD) and regulatory issues. He is  formerly a Senior Staff Fellow At the FDA CDER’s Office of Pharmaceutical Sciences, and a member of FDA’s original PAT Team. He was previously a senior engineer for AstraZeneca. Ali earned his Bs.C. in applied chemistry from Cardiff University and his Ph.D. from the University of Manchester.


Jim Bray, Sc.D.
Convergent Consulting, LLC

Jim Bray currently leads Convergent Consulting based in Raleigh, North Carolina.  He previously served as Interim CEO and as a member of the Board of Directors for Natrix. Previously, Jim was President of PTI Advanced Filtration, a manufacturer of high technology separation and purification products for MicroElectronics, Ultra-pure Chemical, BioPharmaceutical, Food and Beverage and Industrial markets.  Prior to PTI, Jim spent more than 18 years in senior leadership positions at Millipore Corporation.  Jim holds a B.S. in chemical engineering from North Carolina State University, a Sc.D. in chemical engineering from the Massachusetts Institute of Technology (MIT) and an M.B.A. from the University of Connecticut.



Alain Pralong, Ph.D.
Vice President - New Product Introduction & Industrialization
GlaxoSmithKline Biologicals

Alain Pralong is Vice President for New Product Introduction and Industrialization for GSK Biologicals. Previously, he was Vice President of Process Development at Crucell, where he led the implementation of single-use biomanufacturing technologies.  Alain has also held positions with Merck Serono, Roche and Schering-Plough Research Institute.  He earned his Ph.D. in PhD, Biochemistry, Moleceular and Cellular Biology at the University of Berne.


Tom Ransohoff
Vice Presient & Senior Consultant
BioProcess Technology Consultants

Tom Ransohoff is Vice President and Senior Consultant at BioProcess Technology Consultants based near Boston, Massachusetts.  He was previously President & CEO of BioFlash Partners, a developer of innovative single-use separations technology for the biopharmaceutical market. Tom has also held senior positions at TranXenoGen, Inc., Dyax, and Repligen Corporation.  He is a graduate of the Massachusetts Institute of Technology (MIT) and earned his M.S. in chemical engineering at the University of California, Berkeley.